North Dakota State Investment Board purchased a new position in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) during the fourth quarter, HoldingsChannel reports. The firm purchased 9,773 shares of the medical research company’s stock, valued at approximately $1,330,000.
Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Flynn Zito Capital Management LLC raised its stake in shares of Agilent Technologies by 3.2% in the third quarter. Flynn Zito Capital Management LLC now owns 2,257 shares of the medical research company’s stock worth $290,000 after purchasing an additional 69 shares during the last quarter. Gabelli Funds LLC raised its stake in shares of Agilent Technologies by 1.1% in the third quarter. Gabelli Funds LLC now owns 6,620 shares of the medical research company’s stock worth $850,000 after purchasing an additional 74 shares during the last quarter. Fiduciary Trust Co raised its stake in shares of Agilent Technologies by 1.6% in the third quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock worth $633,000 after purchasing an additional 77 shares during the last quarter. NorthCrest Asset Manangement LLC raised its stake in shares of Agilent Technologies by 1.6% in the fourth quarter. NorthCrest Asset Manangement LLC now owns 5,082 shares of the medical research company’s stock worth $726,000 after purchasing an additional 79 shares during the last quarter. Finally, Freestone Capital Holdings LLC raised its stake in shares of Agilent Technologies by 2.0% in the fourth quarter. Freestone Capital Holdings LLC now owns 4,218 shares of the medical research company’s stock worth $574,000 after purchasing an additional 84 shares during the last quarter.
Wall Street Analysts Forecast Growth
Several analysts have recently commented on the company. Morgan Stanley lowered their price objective on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a research note on Tuesday, March 3rd. Wells Fargo & Company lowered their price objective on Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating for the company in a research note on Thursday, February 26th. Barclays lowered their price objective on Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. HSBC started coverage on Agilent Technologies in a research note on Tuesday, January 20th. They issued a “buy” rating and a $180.00 price objective for the company. Finally, Wall Street Zen lowered Agilent Technologies from a “buy” rating to a “hold” rating in a report on Saturday, May 9th. Two investment analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $163.71.
Agilent Technologies Price Performance
Shares of NYSE A opened at $110.43 on Wednesday. The stock has a fifty day simple moving average of $114.85 and a two-hundred day simple moving average of $130.10. Agilent Technologies, Inc. has a 1-year low of $107.07 and a 1-year high of $160.27. The firm has a market cap of $31.21 billion, a price-to-earnings ratio of 24.38, a price-to-earnings-growth ratio of 2.36 and a beta of 1.22. The company has a current ratio of 2.07, a quick ratio of 1.59 and a debt-to-equity ratio of 0.44.
Agilent Technologies (NYSE:A – Get Free Report) last announced its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing the consensus estimate of $1.37 by ($0.01). Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The firm had revenue of $1.80 billion for the quarter, compared to the consensus estimate of $1.81 billion. During the same period last year, the company posted $1.31 earnings per share. Agilent Technologies’s revenue for the quarter was up 7.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. Analysts anticipate that Agilent Technologies, Inc. will post 5.95 earnings per share for the current year.
Agilent Technologies Company Profile
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
Featured Articles
- Five stocks we like better than Agilent Technologies
- HIVE Weaponizes Power for an AI Pivot
- A Deep Dive Into NVIDIA’s Latest Portfolio Moves
- Brady Corp Wires Up a Massive AI-Powered Breakout
- Why Home Depot’s Sell-Off Could Become a Huge Opportunity
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
